<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25-viruses-11-00678">
 <label>25.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Natesan</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Jensen</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Keasey</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Kamata</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kuehne</surname>
    <given-names>I.E.</given-names>
   </name>
   <name>
    <surname>Stonier</surname>
    <given-names>S.W.</given-names>
   </name>
   <name>
    <surname>Lutwama</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Lobel</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Dye</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Ulrich</surname>
    <given-names>R.G.</given-names>
   </name>
  </person-group>
  <article-title>Human survivors of disease outbreaks caused by Ebola or Marburg virus exhibit cross-reactive and long-lived antibody responses</article-title>
  <source>Clin. Vaccine Immunol.</source>
  <year>2016</year>
  <volume>23</volume>
  <fpage>717</fpage>
  <lpage>724</lpage>
  <pub-id pub-id-type="doi">10.1128/CVI.00107-16</pub-id>
  <pub-id pub-id-type="pmid">27335383</pub-id>
 </element-citation>
</ref>
